文献速递主动脉疾病

降主动脉瘤胸主动脉腔内修复术后长期随访中再干预与生存的预测因素

Predictors for reintervention and survival during long-term follow-up after thoracic endovascular aortic repair for descending thoracic aortic aneurysm.
PubMed 文献 · J Vasc Surg · 2024-07-26

这项多中心回顾性病例系列纳入1999至2021年四家学术机构305例因退行性降主动脉瘤接受胸主动脉腔内修复术的患者,分析长期结局。随访显示1、5、10年总生存率分别为76%、59%、34%,免于再干预率分别为84%、73%、58%;美国麻醉医师协会3至5级和非择期手术是死亡的预测因素,梭形动脉瘤、近端锚定区2区和高血压是再干预的预测因素,而器械世代不是。

要点

  • 305例降主动脉瘤患者接受胸主动脉腔内修复术,平均主动脉直径64 mm,技术成功率94%。
  • 1、5、10年总生存率分别为76%、59%、34%,免于再干预率分别为84%、73%、58%。
  • 美国麻醉医师协会3至5级和非择期手术预测死亡;梭形动脉瘤、近端锚定区2区和高血压预测再干预。

核心结论

  • 本研究报告了胸主动脉腔内修复术治疗降主动脉瘤的长期(10年)结局,长期生存率和免于再干预率可接受,且不依赖于血管内器械世代。

研究设计与样本

  • 回顾性多中心病例系列,复习四家学术机构数据库,纳入1999至2021年因退行性降主动脉瘤连续接受胸主动脉腔内修复术的305例患者(平均年龄72±10岁),已获机构审查委员会伦理批准。

主要发现

  • 305例患者平均主动脉直径为64 mm,经股动脉入路植入445枚覆膜支架(93%),技术成功率为94%。
  • 手术死亡率为6%(完整降主动脉瘤为5%,破裂降主动脉瘤为12%),卒中率为4%,脊髓缺血率为3%。
  • Kaplan-Meier估计的1、5、10年总生存率分别为76%、59%和34%,免于再干预率分别为84%、73%和58%。
  • 多因素分析中,美国麻醉医师协会3至5级和非择期手术被确定为死亡的预测因素,梭形降主动脉瘤、近端锚定区2区和高血压预测再干预,而器械世代不是预测因素。

临床怎么用

  • 作者认为,胸主动脉腔内修复术治疗降主动脉瘤的长期生存率和免于再干预率可接受,且不依赖于血管内器械世代。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Several studies have reported short- and intermediate-term outcomes after thoracic endovascular aortic repair (TEVAR) for descending thoracic aortic aneurysm (DTAA); however, reports on long-term (10 years) outcomes are sparse. Therefore, the aim of this study was to analyze predictors impacting long-term outcome after TEVAR for DTAA. METHODS: Databases from four academic institutions were reviewed and consecutive cases of TEVAR for DTAA between 1999 and 2021 were included in this retrospective multicenter study (case series). Ethical approval from the institutional review board was obtained and patient demographics and treatment data, as well as follow-up information were retrieved and analyzed. RESULTS: We identified 305 patients (mean age, 72 ± 10 years) who were treated with TEVAR for degenerative DTAA with a mean aortic diameter of 64 mm. Altogether 445 endografts were implanted via femoral access (93%) with a technical success of 94%. Operative mortality, stroke rate, and rate of spinal cord ischemia were 6% (5% for intact, 12% for ruptured DTAA), 4%, and 3%, respectively. Kaplan-Meier estimates for overall survival rates were 76%, 59% and 34% at 1, 5 and 10 years and freedom from reintervention rates were 84%, 73% and 58% at 1, 5 and 10 years, respectively. In multivariate analysis, American Society of Anesthesiologists grade 3 to 5 and nonelective case were identified as predictors for death, whereas as fusiform DTAA, proximal landing zone 2, and hypertension, but not device generation, were predictive for reintervention. CONCLUSIONS: This study is, to date, the largest reporting long-term (10 years) outcome on TEVAR for DTAA. We found acceptable rates for long-term survival and freedom from reintervention that were independent of endovascular device generation.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Salem O, El Beyrouti H, Mulorz J, et al. Predictors for reintervention and survival during long-term follow-up after thoracic endovascular aortic repair for descending thoracic aortic aneurysm. J Vasc Surg. 2024. PMID: 39069015. doi:10.1016/j.jvs.2024.07.087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。